Virginia Mason Cancer Institute — Seattle, Washington

Virginia Mason Cancer Institute is a clinical research site located in Seattle, Washington, United States 98111.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Virginia Mason Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Carcinoma, Non Small Cell Lung Carcinoma, Irinotecan Sensitive Cancers.

Sponsors: Cancer Research and Biostatistics Clinical Trials Consortium.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Mason Cancer Institute?

Virginia Mason Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Mason Cancer Institute conducted?

Virginia Mason Cancer Institute has 1 clinical trials on record. Their work covers Small Cell Lung Carcinoma, Non Small Cell Lung Carcinoma, Irinotecan Sensitive Cancers.

Is Virginia Mason Cancer Institute accredited by Crixeo Health?

Virginia Mason Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Mason Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.